Pilot-testing the Effect of Magnetic Mitohormesis Therapy for Treating Frailty in Older Adults

Status unconfirmed · Not applicable · Has a placebo group

Conditions studied: Frailty

In brief

Thirty (30) adults with limited physical function will be recruited to participate in a double-blind pilot randomized controlled crossover trial in which all participants will receive 12-weeks of twice weekly MMT treatment in the first (Phase 1) or second half (Phase 2) of the study period; during the control period, participants will receive sham treatment and will be blinded to the randomization.

Key facts

Study ID

NCT05930470

Run by

Auburn University

People needed

30

Starts

2023-04-26

Expected to finish

2024-12-30

Last updated by the study team

2023-07-05

Who can join

Age: 60 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• physical frailty or pre-frailty, indicated by Short Physical Performance Battery Score <10;
• intact cognition indicated by a Mini-Cog Screening Test Score > 2;
• able to read and write in English; and
• access to a telephone.

You may not qualify if…

• active malignancy;
• neuro-degenerative disease
• active electronic implants;
• any health conditions that would prevent performing the testing and intervention procedures;
• major surgical procedures within the last 6 months;
• major change in prescription medications within the last 3 months

Where it is running

• Auburn University — Auburn, Alabama, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.